GB1424432A - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- GB1424432A GB1424432A GB1415873A GB1415873A GB1424432A GB 1424432 A GB1424432 A GB 1424432A GB 1415873 A GB1415873 A GB 1415873A GB 1415873 A GB1415873 A GB 1415873A GB 1424432 A GB1424432 A GB 1424432A
- Authority
- GB
- United Kingdom
- Prior art keywords
- penicillamine
- compositions
- march
- radical
- acyl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- VVNCNSJFMMFHPL-VKHMYHEASA-N D-penicillamine Chemical compound CC(C)(S)[C@@H](N)C(O)=O VVNCNSJFMMFHPL-VKHMYHEASA-N 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 229960001639 penicillamine Drugs 0.000 abstract 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 abstract 1
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical compound [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 abstract 1
- SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical compound NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 abstract 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 229940087168 alpha tocopherol Drugs 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 230000001741 anti-phlogistic effect Effects 0.000 abstract 1
- 229940125715 antihistaminic agent Drugs 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 150000005840 aryl radicals Chemical class 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- VVNCNSJFMMFHPL-UHFFFAOYSA-N penicillamine Chemical class CC(C)(S)C(N)C(O)=O VVNCNSJFMMFHPL-UHFFFAOYSA-N 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 150000003254 radicals Chemical class 0.000 abstract 1
- 229960000581 salicylamide Drugs 0.000 abstract 1
- 229910052709 silver Inorganic materials 0.000 abstract 1
- 230000002048 spasmolytic effect Effects 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
- 229960000984 tocofersolan Drugs 0.000 abstract 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 abstract 1
- 235000013619 trace mineral Nutrition 0.000 abstract 1
- 239000011573 trace mineral Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 235000004835 α-tocopherol Nutrition 0.000 abstract 1
- 239000002076 α-tocopherol Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2214814A DE2214814A1 (de) | 1972-03-25 | 1972-03-25 | Zubereitungen, die vollsynthetisch hergestelltes d-penicillamin enthalten |
| DE19722233993 DE2233993A1 (de) | 1972-07-11 | 1972-07-11 | Zubereitungen, die vollsynthetisch hergestelltes d-penicillamin enthalten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1424432A true GB1424432A (en) | 1976-02-11 |
Family
ID=25762971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1415873A Expired GB1424432A (en) | 1972-03-25 | 1973-03-23 | Pharmaceutical compositions |
Country Status (5)
| Country | Link |
|---|---|
| FR (1) | FR2182892B1 (enrdf_load_stackoverflow) |
| GB (1) | GB1424432A (enrdf_load_stackoverflow) |
| IL (1) | IL41868A (enrdf_load_stackoverflow) |
| NL (1) | NL7304113A (enrdf_load_stackoverflow) |
| OA (1) | OA04527A (enrdf_load_stackoverflow) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4847297A (en) * | 1985-06-08 | 1989-07-11 | Degussa Aktiengesellschaft | Use of penicillamine for treating immune damaging illnesses |
| WO2019111193A1 (en) * | 2017-12-09 | 2019-06-13 | Kashiv Pharma Llc | A stable pharmaceutical composition comprising penicillamine |
| US11090294B2 (en) | 2009-12-01 | 2021-08-17 | Glaxo Group Limited | Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist |
| US11116721B2 (en) | 2009-02-26 | 2021-09-14 | Glaxo Group Limited | Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2304055C3 (de) * | 1973-01-27 | 1982-04-29 | Degussa Ag, 6000 Frankfurt | Verfahren zur Gewinnung von D- Penicillamin |
| DE2304054C3 (de) * | 1973-01-27 | 1982-04-08 | Degussa Ag, 6000 Frankfurt | Verfahren zur Gewinnung von D-Penicillamin |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1015108A (fr) * | 1946-03-22 | 1952-08-27 | Merck & Co Inc | Procédé de préparation de dérivés de la pénicilline et produits en résultant |
| BE786964A (fr) * | 1971-07-30 | 1973-01-29 | Degussa | Procede pour l'obtention de d-penicillamine |
-
1973
- 1973-03-23 FR FR7310473A patent/FR2182892B1/fr not_active Expired
- 1973-03-23 NL NL7304113A patent/NL7304113A/xx active Search and Examination
- 1973-03-23 GB GB1415873A patent/GB1424432A/en not_active Expired
- 1973-03-24 OA OA54862A patent/OA04527A/xx unknown
- 1973-03-25 IL IL41868A patent/IL41868A/en unknown
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4847297A (en) * | 1985-06-08 | 1989-07-11 | Degussa Aktiengesellschaft | Use of penicillamine for treating immune damaging illnesses |
| US11116721B2 (en) | 2009-02-26 | 2021-09-14 | Glaxo Group Limited | Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol |
| US11090294B2 (en) | 2009-12-01 | 2021-08-17 | Glaxo Group Limited | Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist |
| US12396986B2 (en) | 2009-12-01 | 2025-08-26 | Glaxo Group Limited | Combinations of a muscarinic receptor antagonist and a β-2 adrenoreceptor agonist |
| WO2019111193A1 (en) * | 2017-12-09 | 2019-06-13 | Kashiv Pharma Llc | A stable pharmaceutical composition comprising penicillamine |
Also Published As
| Publication number | Publication date |
|---|---|
| IL41868A0 (en) | 1973-05-31 |
| IL41868A (en) | 1976-02-29 |
| NL7304113A (enrdf_load_stackoverflow) | 1973-09-27 |
| FR2182892A1 (enrdf_load_stackoverflow) | 1973-12-14 |
| OA04527A (fr) | 1980-03-30 |
| AU5367973A (en) | 1974-09-26 |
| FR2182892B1 (enrdf_load_stackoverflow) | 1976-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE831084L (en) | Bicyclic carboxylic acids and esters thereof | |
| IE44942L (en) | Piperazine and piperidine derivatives | |
| GB1205957A (en) | Pharmaceutical compositions comprising 1-pnenoxy-2-aminopropanes | |
| WO1999020639A3 (en) | NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES | |
| GB1181673A (en) | Derivatives of Xanthen and Thiaxanthen and Preparation Thereof | |
| ES463240A1 (es) | Procedimiento para la preparacion de acidos pirazol-1-il-fe-nilaceticos. | |
| IE41440L (en) | Thiatetracyclines | |
| GB1424432A (en) | Pharmaceutical compositions | |
| GB1285400A (en) | Esters of substituted anthranilic acid | |
| IE38979L (en) | Tetrazolyl - quinoxalinecarboxamide derivatives | |
| GB1174051A (en) | Aminophenol Derivatives and Analgesic and Antipyretic Compositions | |
| ES411112A1 (es) | Procedimiento de preparacion de nuevos derivados del 1'1- difenil-etileno. | |
| GB1180794A (en) | Novel Arylhydrazino-Imidazolines and Preparation Thereof | |
| GB1250208A (enrdf_load_stackoverflow) | ||
| ES470296A1 (es) | Mejoras introducidas en un procedimiento para la preparacionde fluormetal-aminoacidos | |
| ES380859A1 (es) | Un procedimiento para la preparacion de derivados de diben-zo-dioxocin. | |
| GB1415471A (en) | Phenylethylamine derivatives | |
| GB1176757A (en) | Quinuclidine Carboxylic Acid Amides | |
| ES455940A1 (es) | Procedimiento para la preparacion de 2,9-dioxatriciclo (4,3,1,03,7) decanos. | |
| AU539986B2 (en) | Nitroso-urea compounds + alkylene amine derivatives of ureas | |
| GB1314952A (en) | 3,4,5-trialkoxy-benzoic acid derivatives and their uses | |
| GB1347598A (en) | Lincomycin derivatives and the manufacture thereof | |
| GB1512101A (en) | Piperazinopyrimidines process for their preparation and use | |
| GB1405767A (en) | Method formulation and pharmaceutical composition for reducing plasma lipid levels | |
| GB1420758A (en) | Anti-ulcer compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |